-
Generic drugs gave Americans access to effective, cheap prescription medications. It’s saved them trillions of dollars over the past few decades. But there are signs this vital industry may be in deep trouble.
-
After 20 years and $200 billion in revenue, Humira — an injectable treatment for autoimmune conditions like rheumatoid arthritis — is losing its monopoly.
-
Evidence is mounting that doctors who receive as little as one meal from a drug company tend to prescribe more expensive, brand-name medications for…
-
Believe it or not, it may be cheaper to pay for a prescription yourself rather than using your insurance. And if that fails, there are other places to turn for help getting the best possible deal.
-
Drugs made from proteins or antibodies are difficult for rival manufacturers to copy. The Food and Drug Administration just approved a copycat drug for cancer patients that shows it can be done.